LexDanaLexDanabeta
Inventor

Ippei Sato

Inventor
Tokyo, JP

Overview

9→
Patents
2006–2020
Patent span
Human necessities
Primary field (CPC A)

Patents· 9 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations32%
C07DHeterocyclic compounds32%
A61KPreparations for medical, dental or toiletry purposes21%
C12NMicroorganisms or enzymes11%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium4%
PatentTitleYear
10,689,393Tetrahydroisoquinoline derivatives202010,259,821Tetrahydroisoquinoline derivatives20199,914,741'Tetrahydroisoquinoline derivatives'20189,447,090'Imidazopyridine compounds'20169,284,295'Tetrahydrobenzothiophene compound'20169,062,032'Aminoalkyl-substituted N-thienylbenzamide derivative'20158,729,068'Tetrahydrobenzothiophene compound'20147,173,033'Nitrogen-containing heterocyclic compound'20077,056,910'1,4,5.6-tetrahydroimidazo[4,5-d]diazepine derivatives or salts thereof'2006

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2006–2020Patents assigned to ASTELLAS PHARMA INC (9)· patent assignee history
2006–2007Based in Tsukuba, JP· patent location history
2014–2016Based in Chuo-ku, JP· patent location history
2015–2020Based in Tokyo, JP· patent location history
2018–2020Patents assigned to CYTOKINETICS INC (3)· patent assignee history
2018Patents assigned to CYTOKINECTICS INCORPORATED (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
ASTELLAS PHARMA INC92006–2020
CYTOKINETICS INC32018–2020
CYTOKINECTICS INCORPORATED12018
Locations
LocationPatentsSpan
Tokyo, JP52015–2020
Chuo-ku, JP22014–2016
Tsukuba, JP22006–2007